ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. - Wikidata - awgldk - TriplyDB

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

http://www.wikidata.org/entity/Q35885511

about

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways Retroviral oncogenes: a historical primer The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene Overexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involution Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer.Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers.E3 ubiquitin ligases in ErbB receptor quantity control.The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients.Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.Estrogen-induced upregulation of Sftpb requires transcriptional control of neuregulin receptor ErbB4 in mouse lung type II epithelial cells.Frequent gene amplification predicts poor prognosis in gastric cancer.Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake ErbB3 downregulation enhances luminal breast tumor response to antiestrogens.ErbB4 is an upstream regulator of TTF-1 fetal mouse lung type II cell development in vitro.Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer.Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.Molecular modeling of ErbB4/HER4 kinase in the context of the HER4 signaling network helps rationalize the effects of clinically identified HER4 somatic mutations on the cell phenotype.Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1.Potential of ErbB4 antibodies for cancer therapy.Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.Molecular regulators of pubertal mammary gland development.Neuregulin 3 and erbb signalling networks in embryonic mammary gland development.Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review.Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies.EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival.A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation.Mesenchymal stem cells exploit extracellular matrix as mechanotransducer.ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.

P2860

Q21261300-F26B30A1-1306-40F0-9AE0-B2CFF6FFE979 Q24300478-D4F77AB6-DB74-4602-B246-D634385B3D69 Q24611142-2C02294F-26F1-4584-87AF-98EB0C6BA0A2 Q24645371-1C4F83F1-F465-44A5-B794-4B8C3B460B32 Q27317285-8697AD9F-A0A1-47A6-B0AC-D0468C2D9272 Q27853060-FF5279C4-7A27-4D8C-8AA2-E4E8E55E36ED Q27853122-87D0CC80-0457-49B6-BEC0-ECE76940CD0F Q30845020-D955F0A3-4DB1-440D-BB11-B3238F94926C Q33977133-7E977402-5A17-4BA3-B408-20E9F6EE0ED1 Q33998459-BD345A56-A517-4978-82DD-95F24CC7684B Q34308692-63C2F5DA-688E-4096-B283-DB6516E62565 Q34349106-1D3FF096-A841-44AC-84E2-48B067A07C36 Q34996222-89BA926F-B1E6-4FD7-8E64-0792FC38BEF4 Q35158595-C4B6A39A-2D0D-40E5-86A3-6B593771D362 Q35198204-5A9A25A2-3E2D-405D-9B0C-ADD0FCA0291B Q35933994-551E35A3-C447-4311-A455-08D93C6B392D Q36162605-946E2F1E-6BC5-4807-A229-F72BD39C3B38 Q36315707-036320B1-204B-45C4-A73B-29C5E2E3E7B3 Q36337964-2795AB91-67C8-4C9F-8F96-0E11DB53E5C0 Q37200831-DAB4D936-0CF8-4DA5-A7A0-79FDA3BCD13D Q37329937-E0A2B37F-CF42-447D-8B60-76B465D506D0 Q37331776-C3A53C2B-467E-4761-961C-FD74533FC0AB Q37360194-6F33DA13-753F-4D4F-B9DF-8C95614821D8 Q37391177-7482C4CA-9D31-4709-9544-4FAAE78DD36D Q37516304-84134FBD-BB0E-4C1F-B382-36B757C294EC Q37602884-8E1C2D60-A14B-4250-8FEA-3C35D5007688 Q37632537-A824EBF8-998D-4557-A83C-DA8C5601C3FB Q37658764-0099A2A3-4930-4EB1-A5C5-249D600DCB1C Q37727542-2CE7B87D-3C74-455C-B3C7-5116D1A319E7 Q37854682-42E710FF-2183-4B91-99DF-F58390CCD39B Q38104664-B3115EDE-4FDB-42C5-AD61-B6FCF4B953BC Q38216175-52EC4C75-E2EB-4718-9003-2CF923E2877C Q38364887-12ECC961-5F4F-485B-BEC3-6B16D45866F9 Q38904675-3EF2BE71-2B1E-4251-AA02-C79BB6D66F82 Q39303587-85DF0B9C-30C5-47B8-A1CB-6C3BF7FDF23D Q41985526-83CB46FE-BBC8-45B5-A6A3-061BF6B5B98C Q43248887-287BEC31-BCFD-4B10-AAEE-2312D541FA33 Q52657273-5EE1DC8F-C7CF-4ABF-94B3-44BDA27BE019 Q54390286-49733F06-D038-4010-AF32-65E45163DE79

P2860

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

http://www.wikidata.org/entity/Q35885511

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@ast

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@en

type

label

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@ast

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@en

prefLabel

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@ast

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@en

P1433

Q35885511-C687271E-B123-4A12-A465-F57AAD3C31D3

P1476

Q35885511-A7A70B0C-1322-40C1-9EA1-5A7596752759

P2093

Q35885511-153E24BE-6706-46E3-A638-2797183D7874

Q35885511-60497B8A-BE35-4BA9-BCE7-81D86529D08D

Q35885511-8B601A63-9601-434F-9905-22E19B727AC3

Q35885511-8EA0AAB2-46B0-4782-BD60-D35E15BCEB3B

P2860

Q35885511-00933F9E-3A98-4B62-B5FF-F2DD5DE70189

Q35885511-0C3EEFFE-79AC-4407-A4B2-898BB3AEC56F

Q35885511-104B6963-4BC2-490F-BE84-5D49CA1DA367

Q35885511-17FAEAB7-A2FF-46FD-890C-DFC05F7E0FAD

Q35885511-1F15658C-E841-4AF8-BDCD-470304D75E65

Q35885511-20CD2973-263F-49DE-8EB6-E266ABBF1F44

Q35885511-22201AFD-EA8C-426F-B48B-44869DA9A7A6

Q35885511-230A1AE6-6851-4A4B-8270-2C781F399781

Q35885511-2873396F-C605-4CE0-905C-5C19AD7C796D

Q35885511-296F22E2-C4B3-46D7-9AC4-192EF5DBA184

P2888

Q35885511-F656097E-A835-4426-BD25-37FF223F6B0B

P304

Q35885511-3792CE15-F0AC-4680-956D-D112DBD7CA81

P31

Q35885511-638151D6-A431-4DF1-9EAB-A6917789B1D9

P356

Q35885511-075D228F-7A70-45FB-ADA8-FE8B3AEDF7C6

P433

Q35885511-4CA6545B-E07B-461F-B5A0-B552171E2C2A

P478

Q35885511-542B5B67-3BBF-4184-A8CD-ED76B5CE2D89

P577

Q35885511-B1DBDE89-04C8-4227-9BB0-19B3DA9FF778

P5875

Q35885511-E11919A2-41EE-4E53-85F4-EF376DC4E691

P698

Q35885511-BDDD44F3-8101-4C58-A7ED-C91265283E5A

P932

Q35885511-F92AF278-3D8C-4B0C-9666-A74EAA15AF76

P356

S10911-008-9080-X

P1433

Journal of Mammary Gland Biology and Neoplasia

P1476

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

@en

P2093

H Shelton Earp

http://www.w3.org/2001/XMLSchema#string

Karen E Strunk

http://www.w3.org/2001/XMLSchema#string

Rebecca S Muraoka-Cook

http://www.w3.org/2001/XMLSchema#string

Shu-Mang Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase

A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells

WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function

The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers

Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells

Identification of heregulin, a specific activator of p185erbB2

P2888

s10911-008-9080-x

P304

235-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10911-008-9080-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5414476

http://www.w3.org/2001/XMLSchema#string

P698

18437540

http://www.w3.org/2001/XMLSchema#string

P932

3325098

http://www.w3.org/2001/XMLSchema#string